Glenmark Pharmaceuticals has informed about press release titled ' The US FDA Approves First Supplemental Abbreviated New Drug Application (sANDA) for Glenmark Pharmaceuticals Manufacturing Facility in Monroe, North Carolina'.
The above information is a part of company’s filings submitted to BSE.